Navigation Links
INVO Bioscience Completes Reverse Merger
Date:2/25/2009

Shares trading under IVOB symbol on OTCBB

BEVERLY, Mass., Feb. 25 /PRNewswire-FirstCall/ -- INVO Bioscience, Inc. ("INVO Bioscience" or "the company"), focused on creating simplified, lower cost treatment option for patients diagnosed with infertility, announced the closing of its reverse merger with Emy's Salsa Aji Distribution Company, Inc. (OTC Bulletin Board: EMYS.OB). Through this transaction, INVO Bioscience, formerly BioXcell becomes a public reporting company and its common stock is listed on the OTCBB under the newly-assigned symbol (OTC Bulletin Board: IVOB). The INVO Bioscience executive team will operate the new company focusing on INVOcell sales globally.

"This is a significant step in the growth of our company," said Kathleen Karloff, Chief Executive Officer of INVO Bioscience. "We are now positioned to execute our vision of providing an innovative, more affordable infertility treatment option to the millions of infertile men and women around the world".

"The INVOcell is a novel medical device that enables egg fertilization and early embryo development in the woman's vaginal cavity. The INVO Procedure will be an important option for patients who cannot afford conventional infertility treatments, enabling more patients to seek treatment and build families," added Claude Ranoux, MD, MS, Founder, President and Chief Scientist, INVO Bioscience.

For additional information about this transaction, see the company's Current Report on Form 8-K/A filed with the Securities and Exchange Commission on February 17, 2009 at www.sec.gov.

About the INVOcell Procedure

The INVOcell and INVO Procedure combine a natural or mild stimulation infertility treatment cycle, using lower amounts of injectable fertility hormones than used in traditional IVF(in vitro fertilization), with intra-vaginal incubation
'/>"/>

SOURCE INVO Bioscience, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
2. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
3. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
4. Ohio Ranks Best in the Midwest for Venture Capital Investment in Health Care Bioscience Industry
5. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
6. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
7. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
8. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
9. Todd R. Nelson Named Chief Executive Officer of eBioscience, Inc.
10. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
11. Pressure BioSciences, Inc. Issued First Patent in Canada
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... SPRING, Md., July 29, 2014  United Therapeutics ... announced its financial results for the second ... continued growth shows that our medicines are ... pulmonary arterial hypertension (PAH)," said Martine Rothblatt, ... Officer. "The commercial launch this quarter of ...
(Date:7/29/2014)... 29, 2014 The first product launch ... generation approach to robotics. What sets Droidles completely apart ... technology that allows them to communicate, share code with ... the internet. , “The invention is the system,” said ... Droidles a life of their own, both physically and ...
(Date:7/29/2014)... 29, 2014 The prestigious "Discovery or ... was recently awarded to Juliana Hillis and Kaylie O’Connell, ... their project, “From an Egg, Everything: America’s First IVF ... entries for the National History Day program during a ... and educators in Washington, D.C. , The growing popularity ...
(Date:7/29/2014)... White papers by Clinovo on CDISC ... have been published by leading pharmaceutical publications Data Basics ... of white papers by Clinovo to have been featured ... Online, and OpenHealthNews. , At the request of SCDM ... Desgrousilliers, 'The Five Essentials of Cloud Computing for ...
Breaking Biology Technology:United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 2United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 3United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 4United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 5United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 6United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 7United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 8United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 9United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 10United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 11United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 12United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 13Droidles, the Social Network of Robots and Open Source Platform for the Internet of Things, Launches for Crowd Funding on IndieGoGo.com 2In Vitro Fertilization (IVF) was the Subject of This Year’s Winning Entry for the Prestigious Library of Congress “Discovery or Exploration in History Award” 2In Vitro Fertilization (IVF) was the Subject of This Year’s Winning Entry for the Prestigious Library of Congress “Discovery or Exploration in History Award” 3Clinovo White Papers Published in Summer 2014 Editions of Leading Medical Device & Pharmaceutical Publications 2Clinovo White Papers Published in Summer 2014 Editions of Leading Medical Device & Pharmaceutical Publications 3
... organizations talk a good game about interpersonal skills, influence and ... a pretty clear chain of command that runs right down ... (DoIT) at the University of Wisconsin-Madison, Annie Stunden ... many more staff with IT responsibilities in other departments on ...
... this year intend to provide more mentorship to the ... during the inaugural competition in 2004. , ,Now that the ... a panel of dozens of judges will narrow the 200 ... for a further round of elimination. Sometime in March they ...
... the important impact that generic pharmaceutical drugs are having ... and growth spurs Big Pharma to invest heavily in ... having any kind of medical health insurance in the ... Canada being rapidly shut by U.S. pharmaceutical companies, the ...
Cached Biology Technology:Annie Stunden, CIO at the University of Wisconsin-Madison 2Annie Stunden, CIO at the University of Wisconsin-Madison 3Annie Stunden, CIO at the University of Wisconsin-Madison 4Coaching available for business-plan contest survivors 2Pharmas will be forced into generic-drug strategy 2Pharmas will be forced into generic-drug strategy 3
(Date:7/29/2014)... the wrong food at a restaurant, don,t blame yourself; blame ... do with what you want and more to do with ... and the selections of over 300 diners, the Cornell study ... Management showed that when it comes to what you ... on the menu and how you imagine it will taste. ...
(Date:7/29/2014)... locomotion. Swimming microorganisms, such as bacteria and spermatozoa, are ... viscous forces exerted by the surrounding fluid. Such ... have found that the direction of propulsion made possible ... a viscoelastic fluid. These findings have been published in ... Alternative Energies and Atomic Energy Commission (CEA), in Le ...
(Date:7/29/2014)... Helping people recover from the debilitating effects of ... requires deep knowledge of neurophysiology as well as ... options and outcomes has been the primary focus ... biomedical engineering, since he joined the NJIT faculty ... whose significance is underscored by substantial funding from ...
Breaking Biology News(10 mins):Menu secrets that can make you slim by design 2Optimum inertial self-propulsion design for snowman-like nanorobot 2Continuing the quest for better stroke therapies 2Continuing the quest for better stroke therapies 3
... " Vaccine " published a paper by the Massachusetts based ... important in neurodegenerative Huntington,s disease can be safely used as ... component of every vaccine is an antigen that elicits specific ... Search for better antigens is one of the most ...
... research into heavy metal contaminant levels in dolphins from ... high mercury levels may be a contributing factor to ... Biological Sciences have confirmed levels of mercury found in ... negative health and mental effects and were higher than ...
... Ill. Caloric intake negatively influences sleep patterns in ... be presented on Tuesday at SLEEP 2008, the 22nd ... The study, authored by Ion Zalcman, of Federal ... healthy volunteers between 20-45 years of age. Food ...
Cached Biology News:A protein sequence associated with Huntington’s disease may become life-saving vaccine component 2Mercury contamination found in stranded Victorian dolphins 2Caloric intake negatively influences healthy adults' sleep patterns 2
Anti 4-hydroxy-2-hexenal (4-HHE) Monoclonal Antibody (HNEJ-2)...
... EnVision™ G|2 Doublestain System is ... generation visualization kit. The kit is ... the simultaneous detection of two different ... is compatible with suitably diluted rabbit ...
... this enzyme exists predominantly as XDH which ... a critical plasma antioxidant. During ischemia, ... radical producing XO by oxidation of essential ... cleavage of the amino-terminus. AO has ...
Mouse monoclonal antibody to Lats2....
Biology Products: